Real-world (RW) characteristics, treatment patterns, and outcomes of patients with cholangiocarcinoma (CCA) treated with pemigatinib.
- Resource Type
- Article
- Source
- Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p444-444, 151p
- Subject
- Language
- ISSN
- 0732183X